Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer

Heterogeneous ribonucleoprotein K (hnRNP K) is a member of the hnRNP family which has several different cellular roles including transcription, mRNA shuttling, RNA editing and translation. Several reports implicate hnRNP K having a role in tumorigenesis, for instance hnRNP K increases transcription of the oncogene c-myc and hnRNP K expression is regulated by the p53/MDM 2 pathway. In this study comparing normal colon to colorectal cancer by proteomics, hnRNP K was identified as being overexpressed in this type of cancer. Immunohistochemistry with a monoclonal antibody to hnRNP K (which we developed) on colorectal cancer tissue microarray, confirmed that hnRNP K was overexpressed in colorectal cancer (P<0.001) and also showed that hnRNP K had an aberrant subcellular localisation in cancer cells. In normal colon hnRNP K was exclusively nuclear whereas in colorectal cancer the protein localised both in the cytoplasm and the nucleus. There were significant increases in both nuclear (P=0.007) and cytoplasmic (P=0.001) expression of hnRNP K in Dukes C tumours compared with early stage tumours. In Dukes C patient's good survival was associated with increased hnRNP K nuclear expression (P=0.0093). To elaborate on the recent observation that hnRNP K is regulated by p53, the expression profiles of these two proteins were also analysed. There was no correlation between hnRNP K and p53 expression, however, patients who presented tumours that were positive for hnRNP K and p53 had a poorer survival outcome (P=0.045).

[1]  J. Ostrowski,et al.  Nuclear shift of hnRNP K protein in neoplasms and other states of enhanced cell proliferation , 2003, British Journal of Cancer.

[2]  Rajendra K. Sharma,et al.  Identification of the SRC pyrimidine-binding protein (SPy) as hnRNP K: implications in the regulation of SRC1A transcription. , 2003, Nucleic acids research.

[3]  Stephen P. Jackson,et al.  hnRNP K: An HDM2 Target and Transcriptional Coactivator of p53 in Response to DNA Damage , 2005, Cell.

[4]  G. Dreyfuss,et al.  Isolation of the heterogeneous nuclear RNA-ribonucleoprotein complex (hnRNP): a unique supramolecular assembly. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Mann,et al.  RNA and RNA Binding Proteins Participate in Early Stages of Cell Spreading through Spreading Initiation Centers , 2004, Cell.

[6]  B. Charroux,et al.  The Levels of the bancal Product, aDrosophila Homologue of Vertebrate hnRNP K Protein, Affect Cell Proliferation and Apoptosis in Imaginal Disc Cells , 1999, Molecular and Cellular Biology.

[7]  H. Leffers,et al.  Identification, molecular cloning, expression and chromosome mapping of a family of transformation upregulated hnRNP-K proteins derived by alternative splicing. , 1994, Journal of molecular biology.

[8]  M. Mandal,et al.  Growth Factors Regulate Heterogeneous Nuclear Ribonucleoprotein K Expression and Function* , 2001, The Journal of Biological Chemistry.

[9]  G. Murray,et al.  Immunohistochemical Localization of Cytochrome P450 CYP1B1 in Breast Cancer with Monoclonal Antibodies Specific for CYP1B1 , 1999, Journal of Histochemistry and Cytochemistry.

[10]  M. Tresini,et al.  Compartmentalization of hnRNP‐K during cell cycle progression and its interaction with calponin in the cytoplasm , 2005, Journal of cellular biochemistry.

[11]  Kavita Shah,et al.  ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation , 2001, Nature Cell Biology.

[12]  S. Vicent,et al.  Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer. , 2003, Lung cancer.

[13]  G. Murray,et al.  Mortalin is over‐expressed by colorectal adenocarcinomas and correlates with poor survival , 2005, The Journal of pathology.

[14]  Graeme I Murray,et al.  The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. , 2006, Biochimica et biophysica acta.

[15]  G. Dreyfuss,et al.  Specific binding of heterogeneous ribonucleoprotein particle protein K to the human c-myc promoter, in vitro. , 1993, The Journal of biological chemistry.

[16]  Rajiv Dhir,et al.  Tissue microarrays: an overview. , 2008, Methods in molecular biology.

[17]  C. Thummel,et al.  An enhancer trap screen for ecdysone-inducible genes required for Drosophila adult leg morphogenesis. , 2000, Genetics.

[18]  N. Standart,et al.  Translation of 15‐lipoxygenase mRNA is inhibited by a protein that binds to a repeated sequence in the 3′ untranslated region. , 1994, The EMBO journal.

[19]  C. Gulmann,et al.  Tissue microarrays: an overview , 2003 .

[20]  Jerzy Ostrowski,et al.  hnRNP K: One protein multiple processes , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[21]  Anne E Willis,et al.  Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo , 2003, Oncogene.

[22]  A. Sakurada,et al.  hnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of the lung. , 2003, Lung cancer.

[23]  S. Curran,et al.  Liver fatty acid binding protein expression in colorectal neoplasia , 2004, British Journal of Cancer.

[24]  J. L. Le Caer,et al.  Heterogeneous Nuclear Ribonucleoprotein (hnRNP) K Is a Component of an Intronic Splicing Enhancer Complex That Activates the Splicing of the Alternative Exon 6A from Chicken β-Tropomyosin Pre-mRNA* , 2002, The Journal of Biological Chemistry.

[25]  J. Ostrowski,et al.  Diverse molecular interactions of the hnRNP K protein , 1997, FEBS letters.